课题基金 / 基金详情

基于GSK3β及其相关自噬信号通路的槐定酸类新化合物IMB-08B抗肝癌作用机理研究

批准号:
81473248
项目类别:
面上项目
资助金额:
70.0 万元
负责人:
邓洪斌
学科分类:
抗肿瘤药物药理
结题年份:
2018
批准年份:
2014
项目状态:
已结题
项目参与者:
李电东、毕重文、秦伟、张娜、刘璐、齐玉娟、王玉风

项目摘要

结项摘要

项目成果

邓洪斌的其他基金

相似基金

相关文献

中文摘要
诱导自噬性细胞死亡是抗肿瘤药物研发的新策略。糖原合成酶激酶3β(GSK3β)及其相关自噬信号通路活性与肝癌发生密切相关,抑制GSK3β活性、提高自噬水平具有抗肝癌作用。前期研究发现我们自主创新、具有全新骨架结构的槐定酸类化合物IMB-08B具有明确的抗肝癌作用,可抑制肝癌细胞中GSK3β的活性,诱导自噬性细胞死亡的发生,并具有较好的成药性特征。 本项目拟在此原创性工作基础上,以GSK3β是TAB2的新作用分子及GSK3β调控c-FLIP表达为依据,深入研究:(1)自噬对IMB-08B抗肝癌作用的影响;(2)IMB-08B通过GSK3β调控TAB2-Beclin1自噬通路的确切机制;(3)IMB-08B通过GSK3β调控c-FLIP-Atg3自噬途径的机理,力求阐明IMB-08B通过GSK3β及相关自噬信号通路抑制肝癌生长的分子机制,为槐定酸类化合物抗肿瘤的信号通路机制研究提供新思路。
英文摘要
Hepatocellular cancer (HCC) is the fifth most common malignancy and a major health burden worldwide. Therefore, a thorough understanding of the molecular carcinogenic mechanisms and development of efficacious therapeutics of HCC is a global scientific challenge. Overwhelming evidence implicates that increased Glycogen synthase kinase3β (GSK3β) activity and reduced autophagy may promote the development of HCC pathogenesis, thus therapeutic targeting of the GSK3β and autophagic pathways may be an effective way to enhance the therapeutic activity of anticancer drugs against HCC. During our screening program for natural anticancer drugs against HCC, we have recently discovered that IMB-08B, a novel sophoridinic acid derivative, has potent antihepatocarcinoma activity. Our primary results demonstrated that IMB-08B inhibited hepatoma cell survival by suppressing the activation of GSK3β and increasing the autophagy level. Meanwhile, we also found that GSK3β regulated the autophagy level in hepatoma cell by interacting with TAB2 as well as controlling the expression of c-FLIP. Since TAB2 and c-FLIP inhibition of autophagy through interaction with Beclin1 and Atg3, respectively, we hypothesize that IMB-08B regulates hepatoma cell survival through GSK3β-TAB2-Beclin1 and GSK3β-c-FLIP-Atg3 autophagic pathways. This proposal is novel, as it will demonstrate the effect of autophagy on the antihepatocarcinoma activity of IMB-08B, delineate the molecular mechanism by which IMB-08B regulates autophagic cell death through GSK3β-TAB2-Beclin1 signaling pathway, to elucidate the mechanism of IMB-08B control the autophagic cell death by GSK3-c-FLIP-Atg3 pathway in hepatoma cell with the use of multiple cellular and molecular biotechnologies. This study will clarify a new role of IMB-08B suppressing hepatoma cell survival via GSK3β and its related autohaogic pathways, and provide a theoretical basis for the mechanism study of sophoridinic acid derivatives against HCC.
诱导自噬性细胞死亡是抗肿瘤药物研发的新策略。糖原合成酶激酶3β(GSK-3β)及相关自噬信号通路活性与肿瘤发生密切相关,抑制GSK-3β活性、提高自噬水平具有抗肿瘤作用。我们前期研究证实槐定酸衍生物具有显著的抗肿瘤活性。本研究从多个角度系统阐明了槐定酸类新化合物IMB-08B(后命名为IMB-6G)的抗肿瘤作用及分子机制。我们发现IMB-6G可通过激活肝癌细胞中IRE1α-ASK1和 PERK-CHOP两条内质网应激信号通路,分别引起JNK1磷酸化和Bax转移到线粒体内膜从而诱发内源性细胞凋亡。此外,GSK-3β高表达于肝癌等恶性肿瘤中, IMB-6G可抑制GSK-3β的活性,阻断胰腺癌细胞中的自噬流,促进自噬小体的聚集进而引起溶酶体膜通透性的增加,使Cathepsin B和D从溶酶体转位到细胞质中,诱导胰腺癌细胞凋亡的发生。同时,IMB-6G抑制GSK-3β的活性后,也可通过激活TFEB的转录活性,促进肿瘤细胞中溶酶体的生物合成与活性,从而降解c-FLIP蛋白,诱导自噬性细胞死亡的发生。构效分析结果表明,在槐定酸的N端引入亚芳基可大大提高其抗肿瘤活性,机制是引起肿瘤细胞中溶酶体的pH值升高,阻断自噬流,进而诱发细胞凋亡。本研究阐明了IMB-6G通过GSK-3β及相关自噬信号通路抑制肿瘤生长的分子机制,为槐定酸类化合物发展成为一类新型抗肿瘤药物奠定了基础。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation.
新型小檗碱衍生物的合成和鉴定作为 TNF-α 诱导的 NF-κB 激活的有效抑制剂
DOI: 10.3390/molecules22081257
发表时间: 2017-07-27
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者: [Wang YX, Liu L, Zeng QX, Fan TY, Jiang JD, Deng HB, Song DQ]
通讯作者: Song DQ
IMB-6G, a novel N-substituted sophoridinic acid derivative, induces endoplasmic reticulum stress-mediated apoptosis via activation of IRE1α and PERK signaling.
IMB-6G 是一种新型 N 取代槐啶酸衍生物,通过激活 IRE1alpha 和 PERK 信号传导诱导内质网应激介导的细胞凋亡。
DOI: 10.18632/oncotarget.8184
发表时间: 2016-04-26
期刊: Oncotarget
影响因子: --
作者: [Zhang N, Bi C, Liu L, Dou Y, Tang S, Pang W, Deng H, Song D]
通讯作者: Song D
DOI: --
发表时间: 2017
期刊: 药学学报
影响因子: --
作者: [庞伟强, 高磊, 窦玥莹, 刘璐, 张娜, 刘晓嘉, 刘阳, 杨兆勇, 宋丹青, 邓洪斌]
通讯作者: 邓洪斌
Glycogen synthase kinase-3beta antagonizes ROS-induced hepatocellular carcinoma cell death through suppression of the apoptosis signal-regulating kinase 1.
糖原合成酶激酶 3beta 通过抑制凋亡信号调节激酶 1 来拮抗 ROS 诱导的肝细胞癌细胞死亡。
DOI: 10.1007/s12032-016-0776-2
发表时间: 2016
期刊: Med Oncol
影响因子: --
作者: [Na Zhang, Lu Liu, Yueying Dou, Danqing Song, Hongbin Deng]
通讯作者: Hongbin Deng
12
    基于TFEB-溶酶体途径激活树突状细胞(DCs)-CD4+T细胞轴的黄腐酚衍生物XN-H7抗肿瘤免疫作用机制研究
    基于MITF途径双重下调免疫检查点FGL1和PD-L1的土贝母苷甲类新化合物TBM-19抗肿瘤免疫作用及机制研究
    基于溶酶体途径下调免疫检查点PD-L1的莲心碱类新化合物IMB-29抗非小细胞肺癌作用及机制研究
    IKK与JNK信号通路促进炎性衰老的分子机理研究
    国内基金
    海外基金